Transaction · 0001193125-26-424428

Kelly Thomas Patrick

Kelly Thomas Patrick, CFO, reported a transaction classified as exercise at Xenon Pharmaceuticals Inc. involving 7500.000000 shares for an estimated $0.00. Reported holdings after the transaction were 22500.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCFO
XENEXenon Pharmaceuticals Inc.
Trade date
Oct 15, 2026
Filing date
Oct 17, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded7.50k$0.00 per share
Holdings after22.5kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

XENE price since this filing

Daily closing prices, with the filing date and available return windows
XENE · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +68.1%1w ago +7.9%1d ago +1.2%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001193125-26-424428
Restricted Share Units
Transaction date
Oct 15, 2026
Filed Oct 17, 2026, 12:22 AM · 2d delay
Shares
7,500 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
22,500 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on October 15, 2025. The RSU award vests 25% on each of the first four anniversaries of…

Original filing · 0001193125-26-424428
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

XENE